Results 171 to 180 of about 865,910 (294)
Bioprinted Constructs in the Regulatory Landscape: Current State and Future Perspectives
Bioprinting has rapidly emerged as a transformative technology in biomedical research, offering unprecedented potential to replicate complex tissues. Despite its promise, clinical translation remains limited due to regulatory hurdles. This review explores global regulatory frameworks, comparing approaches in the EU, U.S., China, and Australia, and ...
Francesca Perin +6 more
wiley +1 more source
Th17 cell pathogenicity in autoimmune disease. [PDF]
Park E, Ciofani M.
europepmc +1 more source
This review explores how antibody engineering and display technologies are driving therapeutic advances against mosquito‐borne orthoflaviviruses such as Zika, dengue, and yellow fever viruses. It highlights diverse neutralizing targets on the envelope protein, including the conserved fusion loop, and discusses how Fc engineering, rational antigen ...
Ana Clara Barbosa Antonelli +5 more
wiley +1 more source
Association of Individual or Family History of Autoimmune Disease With Future Development of Type 1 Diabetes. [PDF]
Thomas N +8 more
europepmc +1 more source
Rheumatoid arthritis is a disease characterized by joint inflammation. Approximately 50% of patients show insufficient response to traditional synthetic disease‐modifying antirheumatic drugs. This study aims to elucidate differential molecular profiles of the mechanisms underlying drug responses through multi‐omics strategy.
Congcong Jian +26 more
wiley +1 more source
Transglutaminase 2 and Ferroptosis: a new liaison?
Mara Gagliardi +4 more
doaj +1 more source
Using the convolutional neural network model VDLIN, Co7 is identified as a promising therapeutic candidate. Co7 demonstrates distinct advantages over MCB by effectively balancing anti‐inflammatory and immune‐stimulatory functions, making it a potential novel approach for immune modulation.
Xuefei Guo +6 more
wiley +1 more source
Advances and prospects of CAR-T cell therapy in autoimmune disease treatment. [PDF]
Wang T, Fu T, Xing G, Cai H, Tong Y.
europepmc +1 more source

